On CNBC's “Mad Money Lightning Round,” Jim Cramer said Affirm Holdings Inc AFRM is a buy. “It's at $72, it's going to $100,” he noted.
On the earnings front, Affirm will announce its fourth quarter fiscal year results after the closing bell on Aug. 28.
When asked about Eli Lilly And Co LLY, he said, “Down here, I begin to think that we are too negative on it. But I am very upset with Lilly and the way they handled this, and I think they should come back on and talk to me.”
As per the recent news, Eli Lilly, on Aug. 7, released topline data from the Phase 3 ATTAIN-1 trial evaluating orforglipron, an investigational oral glucagon-like peptide-1 (GLP-1) receptor agonist.
“I don't want to be connected with Brazil,” Cramer said when asked about Banco Bradesco SA BBD. “It's had a big run. If you want an overseas bank, I think you should be in Santander.”
On May 28, Citigroup analyst Rafael Frade upgraded Bank Bradesco from Neutral to Buy.
Cramer said, “I think longer term, ServiceNow NOW has really good AI, and it would not be a stock that I would want to bet against. So, ServiceNow longer term I think is fine. Shorter term I think it's going to be under pressure.”
ServiceNow, on July 23, reported second-quarter revenue of approximately $3.22 billion, beating the consensus estimate of $3.12 billion, according to Benzinga Pro. The company reported second-quarter adjusted earnings of $4.09 per share, beating analyst estimates of $3.57 per share.
Price Action:
Read Next:
Image: Shutterstock
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。